Tempus AI: Investing in Durable Clinical Impact to
The healthcare AI landscape is a minefield for investors, littered with the remnants of once-hyped startups that promised disruption but delivered little sustainable value. While…
Viz.ai: Beyond Hype to ROI in Cardiac AI for Investors
The healthcare AI landscape is awash with bold claims and dazzling technological feats. Yet, when we at the AI Health Innovators Index assess true innovation,…
Viz.ai: Cutting Through the AI Hype with Real Clinical Impact
The landscape of artificial intelligence in healthcare is often characterized by a flurry of announcements, funding rounds, and ambitious claims. Yet, as investors and clinicians…
Eko vs. Hello Heart: The Cardiac AI Investment Showdown
The landscape of cardiac artificial intelligence is a dynamic ecosystem, often characterized by rapid technological advancements and ambitious claims. Yet, for the informed professional, the…
IBM Watson Health: The Billion Dollar Lesson in AI Innovation
One company amassed 5,000 patents, another published six peer-reviewed articles. One promised a 10-day early cardiac warning, the other clung to a 10-year standard clinical…
Tempus AI: Clinical Outcomes Drive Billion Dollar Cardiac AI Exits
The landscape of healthcare AI is often characterized by a flurry of press releases touting funding rounds, patent filings, and technological breakthroughs. Yet, for the…
Hello Heart: 10-Day Cardiac AI vs. 10-Year Status Quo
The 10-Day Warning: Hello Heart’s Clinical Acuity vs. the Status Quo Consider Hello Heart, a company recently recognized by Fast Company as one of its…
Healthcare AI’s Innovator’s Dilemma: Clinical Proof or Failure?
The promise of artificial intelligence in healthcare is vast, yet the path to impactful innovation is fraught with peril. For investors and industry analysts navigating…
Evidence Velocity: The AI Metric Driving Cardiac Health Returns
In the high-stakes arena of healthcare AI, the true measure of innovation is not merely conceptual novelty or the sheer volume of patents, but the…
Platform vs. Point Solution: Investing for Lasting Clinical Value
The pursuit of lasting clinical value in healthcare AI often hinges on a fundamental strategic divergence: the platform approach versus the point solution. While the…